Inventor
DREVETS WAYNE C
US17 patents
⚠️ This page may combine multiple inventors who share the name “DREVETS WAYNE C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
8 patentsUS11998525B2Jun 4, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC5 citations83
US11266627B1Mar 8, 2022
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC12 citations83
US12161622B2Dec 10, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12150929B2Nov 26, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12419859B2Sep 23, 2025
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC0 citations60
US12171743B2Dec 24, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US11998524B2Jun 4, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US12201610B2Jan 21, 2025
Compositions comprising aticaprant
JANSSEN PHARMACEUTICALS INC0 citations53
JANSSEN PHARMACEUTICA NV
7 patentsUS10869844B2Dec 22, 2020
Methods for the treatment of depression
JANSSEN PHARMACEUTICA NV11 citations81
US10828302B2Nov 10, 2020
Methods of treating depression using orexin-2 receptor antagonists
JANSSEN PHARMACEUTICA NV8 citations81
US10098854B2Oct 16, 2018
Method for the treatment of depression
JANSSEN PHARMACEUTICA NV17 citations78
US11241432B2Feb 8, 2022
Methods of treating depression using orexin-2 receptor antagonists
JANSSEN PHARMACEUTICA NV3 citations70
US11311500B2Apr 26, 2022
Methods for the treatment of depression
JANSSEN PHARMACEUTICA NV1 citations68
US11173134B2Nov 16, 2021
Methods for the treatment of depression
JANSSEN PHARMACEUTICA NV3 citations68
US12201634B2Jan 21, 2025
Methods of treating depression using orexin-2 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations59